A first in human study of alpha-synuclein-PET tracers for Parkinson's disease
Phase of Trial: Phase I
Latest Information Update: 02 May 2018
At a glance
- Drugs Alpha-synuclein-PET tracers (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; First in man
- 02 May 2018 According to an AC Immune media release, data were presented at he AAT-AD/PD Focus Meeting 2018 on March 15, 2018.
- 21 Mar 2018 New trial record
- 15 Mar 2018 According to an AC immune media release, the study is scheduled for second half of 2018.